Minneapolis, MN, United States of America

Daniel Zachs

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Regents of the University of Minnesota. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Daniel Zachs in Ultrasound and Electrical Stimulation

Introduction

Daniel Zachs is an innovative inventor based in Minneapolis, MN. He has made significant contributions to the field of medical technology, particularly in the treatment of inflammation and autoimmune disorders. His work focuses on combining ultrasound and electrical stimulation to enhance therapeutic effects.

Latest Patents

Daniel Zachs holds a patent for "Systems and methods for combined ultrasound and electrical stimulation for treating a subject." This patent outlines noninvasive techniques that apply ultrasound stimulation to areas such as the spleen and joints, while also utilizing electrical stimulation to target peripheral nerves. The methods aim to treat conditions like rheumatoid arthritis and other inflammatory disorders. The technology allows for optimized stimulation timings to achieve desired clinical effects, and it includes a wearable ultrasound phased array device that can track the motion of the spleen for localized treatment.

Career Highlights

Zachs is affiliated with the University of Minnesota, where he continues to develop and refine his innovative approaches to medical treatment. His work has the potential to revolutionize how certain conditions are managed, providing noninvasive options for patients.

Collaborations

One of his notable collaborators is Claire Kaiser, who works alongside him in advancing their research and development efforts.

Conclusion

Daniel Zachs is a pioneering inventor whose work in ultrasound and electrical stimulation is paving the way for new treatment methodologies. His contributions are significant in the realm of medical technology, and they hold promise for improving patient outcomes in various inflammatory conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…